Centre Hospitalier de Versailles - Hôpital André Mignot

Le Chesnay 78150

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Leukemia, Myelodysplastic Syndrome

Studies at this site

• A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Completed
• Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) — Completed